British Journal of Cancer - Table of Contents alert Volume 113 Issue 7

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 113, Issue 7 (989-1132) Published online 29 September 2015 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The British Journal of Cancer presents four special Web Focuses in key areas of interest. Click on the links below to access each focus for free. Web Focus on Systemic Inflammation as a Prognostic Marker in Cancer Web Focus on Melanoma, the Great Leap Forward  Web Focus on New Drugs to Watch  Web Focus on The Changing Landscape of Breast Cancer Prognostic Prediction Clinical Studies Top Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort Alix Portal, Simon Pernot, David Tougeron, Claire Arbaud, Anne Thirot Bidault, Christelle de la Fouchardière, Pascal Hammel, Thierry Lecomte, Johann Dréanic, Romain Coriat, Jean-Baptiste Bachet, Olivier Dubreuil, Lysiane Marthey, Laetitia Dahan, Belinda Tchoundjeu, Christophe Locher, Céline Lepère, Franck Bonnetain and Julien Taieb Br J Cancer 2015 113: 989-995; advance online publication, September 15, 2015; 10.1038/bjc.2015.328 Abstract | Full Text Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma L Rossi, E Laas, P Mallon, A Vincent-Salomon, J-M Guinebretiere, F Lerebours, R Rouzier, J-Y Pierga and F Reyal Br J Cancer 2015 113: 996-1002; advance online publication, September 17, 2015; 10.1038/bjc.2015.239 Abstract | Full Text Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma Yann Delpech, Sami I Bashour, Ruben Lousquy, Roman Rouzier, Kenneth Hess, Charles Coutant, Emmanuel Barranger, Francisco J Esteva, Noato T Ueno, Lajos Pusztai and Nuhad K Ibrahim Br J Cancer 2015 113: 1003-1009; advance online publication, September 22, 2015; 10.1038/bjc.2015.308 Abstract | Full Text Translational Therapeutics Top Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers Said A Khelwatty, Sharadah Essapen, Alan M Seddon, Zhen Fan and Helmout Modjtahedi Br J Cancer 2015 113: 1010-1019; advance online publication, September 15, 2015; 10.1038/bjc.2015.319 Abstract | Full Text PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas Jonathan D Black, Salvatore Lopez, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Carlton L Schwab, Diana P English, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz and Alessandro D Santin Br J Cancer 2015 113: 1020-1026; advance online publication, September 1, 2015; 10.1038/bjc.2015.306 Abstract | Full Text Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting Diether Lambrechts, Bernard Thienpont, Vincent Thuillier, Xavier Sagaert, Matthieu Moisse, Gilian Peuteman, Carles Pericay, Gunnar Folprecht, John Zalcberg, Chiara Zilocchi, Emmanuelle Margherini, Marielle Chiron and Eric Van Cutsem Br J Cancer 2015 113: 1027-1034; advance online publication, September 10, 2015; 10.1038/bjc.2015.329 Abstract | Full Text Molecular Diagnostics Top Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers Ruth Exner, Walter Pulverer, Martina Diem, Lisa Spaller, Laura Woltering, Martin Schreiber, Brigitte Wolf, Markus Sonntagbauer, Fabian Schröder, Judith Stift, Fritz Wrba, Michael Bergmann, Andreas Weinhäusel and Gerda Egger Br J Cancer 2015 113: 1035-1045; advance online publication, September 3, 2015; 10.1038/bjc.2015.303 Abstract | Full Text Identification of tumour-reactive lymphatic endothelial cells capable of inducing progression of gastric cancer Mao Watanabe Tokumoto, Hiroaki Tanaka, Yukie Tauchi, Hiroaki Kasashima, Kento Kurata, Masakazu Yashiro, Katsunobu Sakurai, Takahiro Toyokawa, Naoshi Kubo, Ryosuke Amano, Kenjiro Kimura, Kazuya Muguruma, Kiyoshi Maeda, Masaichi Ohira and Kosei Hirakawa Br J Cancer 2015 113: 1046-1054; advance online publication, September 10, 2015; 10.1038/bjc.2015.282 Abstract | Full Text MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker Yusuke Goto, Satoko Kojima, Rika Nishikawa, Akira Kurozumi, Mayuko Kato, Hideki Enokida, Ryosuke Matsushita, Kazuto Yamazaki, Yasuo Ishida, Masayuki Nakagawa, Yukio Naya, Tomohiko Ichikawa and Naohiko Seki Br J Cancer 2015 113: 1055-1065; advance online publication, September 1, 2015; 10.1038/bjc.2015.300 Abstract | Full Text The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer F J A Gujam, D C McMillan, Z M A Mohammed, J Edwards and J J Going Br J Cancer 2015 113: 1066-1074; advance online publication, August 11, 2015; 10.1038/bjc.2015.287 Abstract | Full Text Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays Shazia Akbar, Lee B Jordan, Colin A Purdie, Alastair M Thompson and Stephen J McKenna Br J Cancer 2015 113: 1075-1080; advance online publication, September 8, 2015; 10.1038/bjc.2015.309 Abstract | Full Text Epidemiology Top A prospective study of coffee intake and pancreatic cancer: results from the NIH-AARP Diet and Health Study K A Guertin, N D Freedman, E Loftfield, R Z Stolzenberg-Solomon, B I Graubard and R Sinha Br J Cancer 2015 113: 1081-1085; advance online publication, September 24, 2015; 10.1038/bjc.2015.235 Abstract | Full Text Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC Nora Pashayan, Paul DP Pharoah, Johanna Schleutker, Kirsi Talala, Teuvo LJ Tammela, Liisa Määttänen, Patricia Harrington, Jonathan Tyrer, Rosalind Eeles, Stephen W Duffy and Anssi Auvinen Br J Cancer 2015 113: 1086-1093; advance online publication, August 20, 2015; 10.1038/bjc.2015.289 Abstract | Full Text Comparison of the diagnostic workup of women referred at non-blinded or blinded double reading in a population-based screening mammography programme in the south of the Netherlands Roy J P Weber, Elisabeth G Klompenhouwer, Adri C Voogd, Luc J A Strobbe, Mireille J M Broeders and Lucien E M Duijm Br J Cancer 2015 113: 1094-1098; advance online publication, August 18, 2015; 10.1038/bjc.2015.295 Abstract | Full Text Prospective study of dietary inflammatory index and risk of breast cancer in Swedish women Nitin Shivappa, Sven Sandin, Marie Löf, James R Hébert, Hans-Olov Adami and Elisabete Weiderpass Br J Cancer 2015 113: 1099-1103; advance online publication, September 3, 2015; 10.1038/bjc.2015.304 Abstract | Full Text Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers Lusine Yaghjyan, Andreas Pettersson, Graham A Colditz, Laura C Collins, Stuart J Schnitt, Andrew H Beck, Bernard Rosner, Celine Vachon and Rulla M Tamimi Br J Cancer 2015 113: 1104-1113; advance online publication, September 3, 2015; 10.1038/bjc.2015.315 Abstract | Full Text Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma Debra A Howell, Fiona Warburton, Amanda-Jane Ramirez, Eve Roman, Alexandra G Smith and Lindsay J L Forbes Br J Cancer 2015 113: 1114-1120; advance online publication, September 1, 2015; 10.1038/bjc.2015.311 Abstract | Full Text Aspects of mental health dysfunction among survivors of childhood cancer Miranda M Fidler, Oliver J Ziff, Sarra Wang, Joshua Cave, Pradeep Janardhanan, David L Winter, Julie Kelly, Susan Mehta, Helen Jenkinson, Clare Frobisher, Raoul C Reulen and Michael M Hawkins on behalf of the British Childhood Cancer Survivor Study (BCCSS) Steering Group Br J Cancer 2015 113: 1121-1132; 10.1038/bjc.2015.310 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.